Mouse Model

Drug and Alcohol Rehabilitation: Brentuximab Vedotin.

Brentuximab vedotin.

Filed under: Drug and Alcohol Rehabilitation

Clin Cancer Res. 2012 Nov 15;
Deng C, Pan B, O’Connor OA

Brentuximab vedotin (SGN-35), an intravenously administered CD30-specific antibody-drug conjugate, has recently been approved by the U.S. Food and Drug… Continue reading

Drug and Alcohol Rehabilitation: Galactosylated Chitosan/5-Fluorouracil Nanoparticles Inhibit Mouse Hepatic Cancer Growth and Its Side Effects.

Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.

Filed under: Drug and Alcohol Rehabilitation

World J Gastroenterol. 2012 Nov 14; 18(42): 6076-87
Cheng MR, Li Q, Wan T, He B, Han J, Chen HX, Yang… Continue reading

Depression Treatment: Primary Care of People With Spinal Cord Injury: Scoping Review.

Primary care of people with spinal cord injury: Scoping review.

Filed under: Depression Treatment

Can Fam Physician. 2012 Nov; 58(11): 1207-1216
McColl MA, Aiken A, McColl A, Sakakibara B, Smith K

OBJECTIVE: To perform a scoping review of the… Continue reading

Addiction Rehab: Therapeutic Potential of Monoacylglycerol Lipase Inhibitors.

Therapeutic Potential of Monoacylglycerol Lipase Inhibitors.

Filed under: Addiction Rehab

Life Sci. 2012 Nov 7;
Mulvihill MM, Nomura DK

Marijuana and aspirin have been used for millennia to treat a wide range of maladies including pain and inflammation. Both… Continue reading

Drug and Alcohol Rehabilitation: Treatment With a Nitric Oxide-Donating NSAID Alleviates Functional Muscle Ischemia in the Mouse Model of Duchenne Muscular Dystrophy.

Treatment with a Nitric Oxide-Donating NSAID Alleviates Functional Muscle Ischemia in the Mouse Model of Duchenne Muscular Dystrophy.

Filed under: Drug and Alcohol Rehabilitation

PLoS One. 2012; 7(11): e49350
Thomas GD, Ye J, De Nardi C, Monopoli A, Ongini… Continue reading

Depression Treatment: [Effort-Reward Imbalance at Work and Depression : Current Research Evidence.]

[Effort-reward imbalance at work and depression : Current research evidence.]

Filed under: Depression Treatment

Nervenarzt. 2012 Nov 9;
Siegrist J

In view of highly prevalent stressful conditions in modern working life, in particular increasing work pressure and job insecurity,… Continue reading

[Critical Illness Polyneuropathy and Critical Illness Myopathy.]

[Critical illness polyneuropathy and critical illness myopathy.]

Filed under: Rehab Centers

Med Klin Intensivmed Notfmed. 2012 Oct 28;
Grimm A, Günther A, Witte OW, Axer H

Critical illness polyneuropathy (CIP) and critical illness myopathy (CIM) are frequent complications in… Continue reading

Intranasal Rapamycin Rescues Mice From Staphylococcal Enterotoxin B-Induced Shock.

Intranasal rapamycin rescues mice from staphylococcal enterotoxin B-induced shock.

Filed under: Drug and Alcohol Rehabilitation

Toxins (Basel). 2012 Sep; 4(9): 718-28
Krakauer T, Buckley M

Staphylococcal enterotoxin B (SEB) and related exotoxins produced by Staphylococcus aureus are potent activators… Continue reading

Cotinine: Beyond That Expected, More Than a Biomarker of Tobacco Consumption.

Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption.

Filed under: Addiction Rehab

Front Pharmacol. 2012; 3: 173
Moran VE

A greater incidence of tobacco consumption occurs among individuals with psychiatric conditions including post-traumatic stress disorder (PTSD),… Continue reading

Depression Treatment: GABAergic Control of Critical Developmental Periods for Anxiety- and Depression-Related Behavior in Mice.

GABAergic control of critical developmental periods for anxiety- and depression-related behavior in mice.

Filed under: Depression Treatment

PLoS One. 2012; 7(10): e47441
Shen Q, Fuchs T, Sahir N, Luscher B

Vulnerability for anxiety and depressive disorders is thought to… Continue reading